BR112017006219A8 - Sistema de controle para controle de distribuição de medicamentos - Google Patents

Sistema de controle para controle de distribuição de medicamentos

Info

Publication number
BR112017006219A8
BR112017006219A8 BR112017006219A BR112017006219A BR112017006219A8 BR 112017006219 A8 BR112017006219 A8 BR 112017006219A8 BR 112017006219 A BR112017006219 A BR 112017006219A BR 112017006219 A BR112017006219 A BR 112017006219A BR 112017006219 A8 BR112017006219 A8 BR 112017006219A8
Authority
BR
Brazil
Prior art keywords
epilepsy
patient
medication
data store
systems
Prior art date
Application number
BR112017006219A
Other languages
English (en)
Other versions
BR112017006219A2 (pt
Inventor
Alistair Balfour STEWART Richard
Clarke Anthony
Original Assignee
Zogenix International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54884082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017006219(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zogenix International Ltd filed Critical Zogenix International Ltd
Publication of BR112017006219A2 publication Critical patent/BR112017006219A2/pt
Publication of BR112017006219A8 publication Critical patent/BR112017006219A8/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/24—Querying
    • G06F16/245—Query processing
    • G06F16/2457—Query processing with adaptation to user needs
    • G06F16/24573—Query processing with adaptation to user needs using data annotations, e.g. user-defined metadata
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00—Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Abstract

Um sistema de controlar distribuição de um medicamento no tratamento ou prevenção de epilepsia é fornecido. Um controlador central do sistema tem um armazenamento de dados e um ou mais processadores para ler e gravar dados no armazenamento de dados. O armazenamento de dados compreende um banco de dados de registros de paciente, cada registro de paciente tendo um campo de autorização de medicação. O controlador central pode emitir uma autorização de uma primeira prescrição de medicação de epilepsia para um paciente em função dos resultados de testes genéticos para o paciente e programa um teste subsequente para o paciente antes da autorização de uma prescrição subsequente de medicação de epilepsia. São também fornecidos métodos nos quais os sistemas do assunto encontram utilização. Os sistemas e métodos encontram utilização no tratamento de subtipos graves de epilepsia ou epilepsia refratária, como a Síndrome de Dravet.
BR112017006219A 2014-09-29 2015-09-28 Sistema de controle para controle de distribuição de medicamentos BR112017006219A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462056836P 2014-09-29 2014-09-29
US62/056,836 2014-09-29
PCT/IB2015/002081 WO2016051271A1 (en) 2014-09-29 2015-09-28 Control system for control of distribution of medication

Publications (2)

Publication Number Publication Date
BR112017006219A2 BR112017006219A2 (pt) 2018-03-13
BR112017006219A8 true BR112017006219A8 (pt) 2023-02-14

Family

ID=54884082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017006219A BR112017006219A8 (pt) 2014-09-29 2015-09-28 Sistema de controle para controle de distribuição de medicamentos

Country Status (16)

Country Link
US (3) US10452815B2 (pt)
EP (2) EP3961640A1 (pt)
JP (2) JP6774402B2 (pt)
KR (1) KR102245345B1 (pt)
CN (1) CN107111673B (pt)
AU (2) AU2015326472B2 (pt)
BR (1) BR112017006219A8 (pt)
CA (1) CA2962367A1 (pt)
IL (2) IL251360B (pt)
MX (1) MX2017004065A (pt)
NZ (2) NZ762886A (pt)
RU (1) RU2704749C2 (pt)
SA (1) SA517381207B1 (pt)
SG (1) SG11201702494UA (pt)
WO (1) WO2016051271A1 (pt)
ZA (1) ZA201705078B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3393470B1 (en) 2015-12-22 2021-01-20 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
CN108883399B (zh) 2015-12-22 2021-06-22 周格尼克斯国际有限公司 芬氟拉明组合物及其制备方法
JP2019526544A (ja) 2016-08-24 2019-09-19 ゾゲニクス インターナショナル リミテッド ５−ｈｔ２ｂアゴニストの形成を阻害するための製剤およびその使用方法
US20180075220A1 (en) * 2016-09-12 2018-03-15 National Health Coalition, Inc. Methods for Processing Submission and Fulfillment of Pharmaceutical Prescriptions in Real Time
US10313422B2 (en) * 2016-10-17 2019-06-04 Hitachi, Ltd. Controlling a device based on log and sensor data
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
WO2019140432A1 (en) * 2018-01-15 2019-07-18 Hygieia Health Co., Limited Systems, methods, compositions and devices for personalized nutrition formulation and delivery system
US10599922B2 (en) * 2018-01-25 2020-03-24 X Development Llc Fish biomass, shape, and size determination
JP2021526507A (ja) 2018-05-11 2021-10-07 ゾゲニクス インターナショナル リミテッド 発作により誘発される突然死を処置するための組成物および方法
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
US11398312B2 (en) 2018-06-15 2022-07-26 Xact Laboratories, LLC Preventing the fill of ineffective or under-effective medications through integration of genetic efficacy testing results with legacy electronic patient records
US11227685B2 (en) 2018-06-15 2022-01-18 Xact Laboratories, LLC System and method for laboratory-based authorization of genetic testing
US11527331B2 (en) 2018-06-15 2022-12-13 Xact Laboratories, LLC System and method for determining the effectiveness of medications using genetics
US11380424B2 (en) 2018-06-15 2022-07-05 Xact Laboratories Llc System and method for genetic based efficacy testing
US11749393B2 (en) * 2019-05-31 2023-09-05 Becton, Dickinson And Company Systems, apparatuses and methods for capturing images of medical condition management events and related equipment with smartphone and related app that processes images to reduce medical errors
EP3987536A4 (en) * 2019-06-19 2023-01-11 Hewlett-Packard Development Company, L.P. USE OF MEDICAL TEST RESULTS FOR MEDICAL CARE
US11468320B1 (en) 2019-07-31 2022-10-11 Express Scripts Strategic Development, Inc. Methods and systems for predicting prescription directions using machine learning algorithm
US11510614B1 (en) 2019-12-02 2022-11-29 Express Scripts Strategic Development, Inc. Wearable devices and systems for prescription adherence
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
WO2023084479A2 (en) * 2021-11-15 2023-05-19 Tech Pharmacy Services, Llc Cyber protection for pharmaceutical dispensing systems
WO2023178288A1 (en) 2022-03-17 2023-09-21 Azora Therapeutics, Inc. Companion diagnostics and strategies for treatment with an aryl hydrocarbon receptor agonist compound

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US779717A (en) 1904-10-03 1905-01-10 Frank Klepetko Roasting-furnace.
FR104F (pt) 1960-11-05
US3117160A (en) 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
GB1254332A (en) 1969-02-27 1971-11-17 Science Union & Cie Amino acids and their derivatives and processes for preparing them
DE3717434C1 (de) 1987-05-23 1988-09-15 Degussa Verfahren zur Herstellung von m-Trifluormethylphenylacetonitril
JPH07225800A (ja) * 1994-02-10 1995-08-22 Toshiba Corp 医療機関用診療支援装置
ATE199829T1 (de) 1994-06-03 2001-04-15 Thejmde Trust Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
IT1298349B1 (it) 1996-05-29 2000-01-05 Alfa Chem Ital Processo per la produzione di 1 - (3-trifluorometil) fenil-propan- 2-one intermedio nella sintesi della fenfluramina
IT1292885B1 (it) 1997-04-28 1999-02-11 Alfa Chem Ital Processo per la produzione degli isomeri (r) ed (s)- alfa -metil-3- (trifluorometil)benzene-etanamina.
US6045501A (en) 1998-08-28 2000-04-04 Celgene Corporation Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
ATE238783T1 (de) 1998-12-23 2003-05-15 Orphan Medical Inc Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten
US7124031B1 (en) 2000-05-11 2006-10-17 Medco Health Solutions, Inc. System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records
WO2002006826A1 (en) 2000-07-17 2002-01-24 Opt-E-Scrip, Inc. Single-patient drug trials used with accumulated database
US6315720B1 (en) 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AUPR732601A0 (en) 2001-08-28 2001-09-20 Polychip Pharmaceuticals Pty Ltd Methods for the synthesis of amines such as ephedrine and inter mediates
CA2478183C (en) 2002-03-12 2010-02-16 Merck & Co. Inc. Substituted amides
US7668730B2 (en) 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
US20050260610A1 (en) 2004-05-20 2005-11-24 Kurtz Richard E Method for diagnosing and prescribing a regimen of therapy for human health risk
US9820658B2 (en) * 2006-06-30 2017-11-21 Bao Q. Tran Systems and methods for providing interoperability among healthcare devices
CA2602899A1 (en) 2005-03-21 2006-09-28 Software Solutions Limited System for continuous blood pressure monitoring
US20100088778A1 (en) * 2005-06-16 2010-04-08 John Charles Mulley Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
CA2622967A1 (en) 2005-09-19 2007-03-29 Biolert Ltd. A system and method for detecting an epileptic event
US7464114B2 (en) * 2005-09-27 2008-12-09 International Business Machines Corporation Method and apparatus to capture and transmit dense diagnostic data of a file system
EP3223182A1 (en) * 2005-11-29 2017-09-27 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2007079181A2 (en) 2005-12-28 2007-07-12 Neurovista Corporation Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders
BRPI0707518A2 (pt) * 2006-02-06 2011-05-10 Novartis Ag combinaÇço de compostos orgÂnicos
CN105468895A (zh) * 2006-05-02 2016-04-06 普罗透斯数字保健公司 患者定制的治疗方案
KR200428932Y1 (ko) * 2006-06-28 2006-10-16 조점섭 1회용 각질 제거장치
EP2053961A4 (en) * 2006-08-09 2013-05-01 Biogen Idec Inc METHOD FOR DISPENSING A MEDICAMENT
WO2008023425A1 (fr) * 2006-08-24 2008-02-28 Kirin Holdings Kabushiki Kaisha Composition pour l'amélioration de l'état de la peau
WO2008095095A2 (en) * 2007-01-31 2008-08-07 Quintiles Transnational Corp. Methods and systems for allocating representatives to sites in clinical trials
DE102007025581A1 (de) * 2007-06-01 2008-12-04 Mettler-Toledo (Albstadt) Gmbh Verfahren zum Wiegen eines Wägegutes und Waage zur Durchführung des Verfahrens
US8073563B2 (en) * 2007-06-19 2011-12-06 Omnicell, Inc. Handling of multi-use item systems, methods, and devices
US20090017169A1 (en) * 2007-07-11 2009-01-15 Assaad Kimberly Nicole Method for making hard pretzels that effectively absorb seasoning slurry
MX2011001384A (es) * 2008-08-06 2011-09-27 Gosforth Ct Holdings Pty Ltd Composiciones y metodos para tratar trastornos psiquiatricos.
US8386274B1 (en) 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
TWI424832B (zh) * 2008-12-15 2014-02-01 Proteus Digital Health Inc 與身體有關的接收器及其方法
WO2010104841A2 (en) * 2009-03-09 2010-09-16 Celgene Corporation Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
WO2010124137A1 (en) * 2009-04-22 2010-10-28 Millennium Pharmacy Systems, Inc. Pharmacy management and administration with bedside real-time medical event data collection
CN103025301B (zh) * 2010-03-09 2016-11-09 破赛普提医药有限公司 药物验证和分配
WO2011119227A2 (en) * 2010-03-25 2011-09-29 Columbia Northwest Pharmaceuticals, Llc Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
JP2011221623A (ja) * 2010-04-06 2011-11-04 Kakimori Suri 在宅診療支援システム及び方法
EP2399513B1 (en) * 2010-06-23 2017-01-04 Qatar University Qstp-B System for non-invasive automated monitoring, detection, analysis, characterisation, prediction or prevention of seizures and movement disorder symptoms
CN103189053A (zh) * 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
RU103209U1 (ru) * 2010-10-29 2011-03-27 Общество С Ограниченной Ответственностью "Правовое Сопровождение Бизнеса" Клиническая информационная система
US8796661B2 (en) * 2010-11-01 2014-08-05 Micron Technology, Inc. Nonvolatile memory cells and methods of forming nonvolatile memory cell
JP5693325B2 (ja) * 2011-03-29 2015-04-01 小林クリエイト株式会社 健診結果出力システム及び健診結果出力プログラム
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2013096878A1 (en) * 2011-12-22 2013-06-27 University Of Idaho Garcinia buchananii baker compounds, compositions and related methods
US20130218586A1 (en) 2012-02-21 2013-08-22 Frederic J. Huser Methods and elements for identifying the appropriate patient populations who can safely use prescription chronic care drugs that are switched to an over-the-counter regulatory status
JP6075973B2 (ja) 2012-06-04 2017-02-08 富士通株式会社 健康状態判定装置およびその作動方法
WO2014106825A2 (en) * 2013-01-06 2014-07-10 Jonathan Rabinowitz Methods and devices for identifying improper medical reporting
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
CN103886415A (zh) * 2014-03-25 2014-06-25 北京蝶禾谊安信息技术有限公司 药品管理方法和装置
EP3170807B1 (en) 2015-11-23 2019-12-11 Frau Pharma S.r.l. New method for synthesis of fenfluramine

Also Published As

Publication number Publication date
NZ762886A (en) 2022-02-25
IL251360A0 (en) 2017-05-29
IL251360B (en) 2020-10-29
EP3201808A1 (en) 2017-08-09
US10452815B2 (en) 2019-10-22
AU2015326472A1 (en) 2017-04-13
US10950331B2 (en) 2021-03-16
ZA201705078B (en) 2019-07-31
CA2962367A1 (en) 2016-04-07
CN107111673A (zh) 2017-08-29
KR102245345B1 (ko) 2021-04-28
US20200051686A1 (en) 2020-02-13
WO2016051271A1 (en) 2016-04-07
AU2020202655A1 (en) 2020-05-14
BR112017006219A2 (pt) 2018-03-13
RU2017110222A3 (pt) 2018-11-08
JP2021007038A (ja) 2021-01-21
SA517381207B1 (ar) 2020-06-28
SG11201702494UA (en) 2017-04-27
AU2015326472B2 (en) 2020-05-28
NZ730560A (en) 2020-05-29
RU2017110222A (ru) 2018-11-08
RU2704749C2 (ru) 2019-10-30
EP3201808B1 (en) 2021-10-20
CN107111673B (zh) 2021-03-23
US20210158920A1 (en) 2021-05-27
JP2017528849A (ja) 2017-09-28
US20160092652A1 (en) 2016-03-31
EP3961640A1 (en) 2022-03-02
MX2017004065A (es) 2017-07-24
IL277505A (en) 2020-11-30
KR20170063851A (ko) 2017-06-08
JP6774402B2 (ja) 2020-10-21
IL277505B (en) 2022-03-01

Similar Documents

Publication Publication Date Title
BR112017006219A8 (pt) Sistema de controle para controle de distribuição de medicamentos
BR112015022267A2 (pt) determinação computadorizada de refração e astigmatismo
BR112013033943A2 (pt) sistema para uso com uma ou mais fontes de dados filiados de paciente, métodos para atualizar um conjunto de dados de orientação específico de paciente, atualizar uma pluralidade de bancos de dados de dispositivos de interface de paciente, operar um dispositivo de interface de paciente, administrar dados em um sistema, e, dispositivo de interface de paciente
BR112015022472A2 (pt) método e sistema para prever a resposta a tratamentos para transtornos mentais
BR112017025120A2 (pt) métodos de diagnóstico para terapia de células t
BR112019008930A2 (pt) métodos e sistemas para gerenciar conformidade de paciente
CR20170259A (es) Terapias de envenenamiento y composiciones farmacéuticas, sistemas y equipos relacionados
BR112015028605A8 (pt) uso de uma composição e uso de um imunossupressor e uma composição
BR112014017787A8 (pt) Plataforma e interface de múltiplas atividades
BR112015009948A8 (pt) Antagonistas de ativina-actrii, usos dos mesmos para tratamento de doenças ósseas e outros distúrbios e método para monitorar a eficácia do tratamento ou prevenção de uma doença óssea e outros distúrbios
BR112013016128A2 (pt) "método e sistema de verificação de aplicação de um conjunto de práticas de cuidados coma saúde"
BR112017003312A2 (pt) compostos de indazol como inibidores de fgfr quinase, preparação e uso dos mesmos
EP2911079A3 (en) Healthcare fraud sharing system
BR112016019529A8 (pt) Método implementado por computador e sistema para rastreamento do olhar dos olhos de um usuário
BR102013002579A8 (pt) métodos, sistemas e produtos de programa baseados na localização para execução de uma ação no dispositivo de um usuário
BR112018012130A2 (pt) dispostivo de processamento de dados, e método para a verificação da integridade de um dispositivo de processamento de dados tendo uma pluralidade de componentes de hardware
BR112013017901A2 (pt) sistema para detecção de dispositivo médico, sistema de biopsia para detecção de dispositivo médico e método para detecção de dispositivo médico
BR112015001228A2 (pt) métodos implementado por computador para processar e para reportar resultados de teste de um dispositivo médico, meio de armazenamento legível por computador, e, sistema para reportar resultados de testes médicos.
IN2014KN02583A (pt)
BR112014004465A2 (pt) compostos e composições como inibidores de pdgfr cinase
IN2015DN03826A (pt)
Drolet et al. Vaccination against herpes zoster in developed countries: state of the evidence
MX2015012559A (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
White The globalisation of mental illness.
BR112014003963A2 (pt) compostos e composições como inibidores de quinase c-kit

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: G06F 19/00

Ipc: G16H 20/13 (2018.01), G06F 16/2457 (2019.01), G16H

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]